OABIW on Nasdaq
OmniAb, Inc.
American commercial physical and biological research services company.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with MaxCyte (United States), FOXO TECHNOLOGIES INC. or bioAffinity Technologies, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
-369.5%Operating margin3
-347.0%Net margin3
-29.3%Revenue growth, 20253
-24.3%Return on equity3
-$37.0MFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
License And Milestone Revenue brought in 52% of the revenue OmniAb, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| License And Milestone Revenue | $13.9M | $9.8M |
| Service | $11.9M | $7.3M |
| Royalty | $576.0K | $878.0K |
| xPloration Revenue | $0 | $754.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Research and development97¢$47.8M
- Income tax3¢$1.5M
Out of $18.7M in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total revenue | $18.7M | $26.4M |
| Research and development | $47.8M | $55.1M |
| General and administrative | $29.2M | $30.7M |
| Amortization of intangibles | $12.9M | $17.4M |
| Other operating income, net | -$2.5M | -$2.4M |
| Total costs and operating expenses | $87.6M | $100.9M |
| Loss from operations | -$69.0M | -$74.5M |
| Interest income | $2.7M | $3.1M |
| Other income (expense), net | $15.0K | -$15.0K |
| Total other income (expense), net | $2.7M | $3.1M |
| Loss before income taxes | -$66.3M | -$71.4M |
| Income tax benefit | $1.5M | $9.4M |
| Net loss | -$64.8M | -$62.0M |
| Net loss per share, basic (dollars per share) | -$0.57 | -$0.61 |
| Net loss per share, diluted (dollars per share) | -$0.57 | -$0.61 |
| Weighted-average shares outstanding, basic (in shares) | 113.6M shares | 102.4M shares |
| Weighted-average shares outstanding, diluted (in shares) | 113.6M shares | 102.4M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $25.5M | $27.6M | |
| Short-term investments | $28.5M | $31.8M | |
| Accounts receivable, net | $7.4M | $5.3M | |
| Prepaid expenses and other current assets | $3.9M | $3.4M | |
| Total current assets | $65.3M | $68.1M | |
| Intangible assets, net | $125.1M | $138.1M | |
| Goodwill | $84.0M | $84.0M | |
| Property and equipment, net | $9.4M | $15.5M | |
| Operating lease right-of-use assets | $15.5M | $17.8M | |
| Restricted cash | $560.0K | $560.0K | |
| Other long-term assets | $912.0K | $1.5M | |
| Total assets | $300.9M | $325.6M | |
| Accounts payable | $1.9M | $2.3M | |
| Accrued expenses and other current liabilities | $6.3M | $6.1M | |
| Current contingent liabilities | $1.0M | $531.0K | |
| Current deferred revenue | $3.2M | $2.3M | |
| Current operating lease liabilities | $3.9M | $3.8M | |
| Total current liabilities | $16.3M | $15.1M | |
| Long-term contingent liabilities | $315.0K | $953.0K | |
| Deferred income taxes, net | $785.0K | $2.3M | |
| Long-term operating lease liabilities | $16.5M | $19.4M | |
| Long-term deferred revenue | $0 | $117.0K | |
| Other long-term liabilities | $78.0K | $86.0K | |
| Total liabilities | $33.9M | $37.9M | |
| Preferred stock, $0.0001 par value; 100,000,000 shares authorized; no shares issued and outstanding at December 31, 2025 and December 31, 2024 | $0 | $0 | |
| Common stock, $0.0001 par value; 1,000,000,000 shares authorized at December 31, 2025 and December 31, 2024; 144,308,383 and 121,599,488 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $14.0K | $12.0K | |
| Additional paid-in capital | $433.2M | $389.0M | |
| Accumulated other comprehensive income | $12.0K | $27.0K | |
| Accumulated deficit | -$166.2M | -$101.4M | |
| Total stockholders equity | $267.0M | $287.6M | $314.6M |
| Total liabilities and stockholders equity | $300.9M | $325.6M | |
| Preferred stock, par value, (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | |
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | |
| Common shares, par value, (in dollars per share) | $0.00 | $0.00 | |
| Common shares, shares authorized (in shares) | 1.0B shares | 1.0B shares | |
| Common shares, shares issued (in shares) | 144.3M shares | 121.6M shares | |
| Common shares, shares outstanding (in shares) | 144.3M shares | 121.6M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $25.5M | $27.6M | |
| Short-term investments | $28.5M | $31.8M | |
| Accounts receivable, net | $7.4M | $5.3M | |
| Prepaid expenses and other current assets | $3.9M | $3.4M | |
| Total current assets | $65.3M | $68.1M | |
| Intangible assets, net | $125.1M | $138.1M | |
| Goodwill | $84.0M | $84.0M | |
| Property and equipment, net | $9.4M | $15.5M | |
| Operating lease right-of-use assets | $15.5M | $17.8M | |
| Restricted cash | $560.0K | $560.0K | |
| Other long-term assets | $912.0K | $1.5M | |
| Total assets | $300.9M | $325.6M | |
| Accounts payable | $1.9M | $2.3M | |
| Accrued expenses and other current liabilities | $6.3M | $6.1M | |
| Current contingent liabilities | $1.0M | $531.0K | |
| Current deferred revenue | $3.2M | $2.3M | |
| Current operating lease liabilities | $3.9M | $3.8M | |
| Total current liabilities | $16.3M | $15.1M | |
| Long-term contingent liabilities | $315.0K | $953.0K | |
| Deferred income taxes, net | $785.0K | $2.3M | |
| Long-term operating lease liabilities | $16.5M | $19.4M | |
| Long-term deferred revenue | $0 | $117.0K | |
| Other long-term liabilities | $78.0K | $86.0K | |
| Total liabilities | $33.9M | $37.9M | |
| Preferred stock, $0.0001 par value; 100,000,000 shares authorized; no shares issued and outstanding at December 31, 2025 and December 31, 2024 | $0 | $0 | |
| Common stock, $0.0001 par value; 1,000,000,000 shares authorized at December 31, 2025 and December 31, 2024; 144,308,383 and 121,599,488 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $14.0K | $12.0K | |
| Additional paid-in capital | $433.2M | $389.0M | |
| Accumulated other comprehensive income | $12.0K | $27.0K | |
| Accumulated deficit | -$166.2M | -$101.4M | |
| Total stockholders equity | $267.0M | $287.6M | $314.6M |
| Total liabilities and stockholders equity | $300.9M | $325.6M | |
| Preferred stock, par value, (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | |
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | |
| Common shares, par value, (in dollars per share) | $0.00 | $0.00 | |
| Common shares, shares authorized (in shares) | 1.0B shares | 1.0B shares | |
| Common shares, shares issued (in shares) | 144.3M shares | 121.6M shares | |
| Common shares, shares outstanding (in shares) | 144.3M shares | 121.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$64.8M | -$62.0M |
| Depreciation and amortization | $21.8M | $23.6M |
| Share-based compensation | $15.8M | $21.5M |
| Amortization of discounts on short-term investments, net | -$858.0K | -$1.5M |
| Deferred income taxes, net | -$1.5M | -$9.0M |
| Change in estimated fair value of contingent liabilities | $325.0K | -$2.5M |
| Gain on sale of ion channel asset | -$3.0M | $0 |
| Other | $761.0K | $544.0K |
| Accounts receivable, net | $189.0K | -$625.0K |
| Prepaid expenses and other current assets | -$1.1M | $642.0K |
| Other long-term assets | $628.0K | $645.0K |
| Accounts payable, accrued expenses, and other liabilities | -$231.0K | -$2.4M |
| Operating lease liabilities | -$2.8M | -$2.4M |
| Deferred revenue | -$1.6M | -$6.0M |
| Net cash used in operating activities | -$36.5M | -$39.7M |
| Purchases of short-term investments | -$46.9M | -$40.3M |
| Proceeds from maturity of short-term investments | $50.8M | $78.0M |
| Purchases of property and equipment | -$565.0K | -$1.9M |
| Payments of contingent liabilities | $0 | -$400.0K |
| Proceeds from sale of short-term investments | $90.0K | $2.4M |
| Proceeds from sale of ion channel asset | $3.0M | $0 |
| Net cash provided by investing activities | $6.5M | $37.9M |
| Payments of contingent liabilities | -$450.0K | -$75.0K |
| Proceeds from issuance of common stock from stock plans | $489.0K | $3.3M |
| Taxes paid related to net share settlement of equity awards | $0 | -$960.0K |
| Proceeds from issuance of common stock in private placement, net of commissions | $28.2M | $0 |
| Proceeds from issuance of common stock under ATM facility, net of commissions | $0 | $11.4M |
| Payment of transaction costs | -$324.0K | -$571.0K |
| Net cash provided by financing activities | $27.9M | $13.0M |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -$2.1M | $11.2M |
| Right-of-use assets obtained in exchange for lease obligations: | $0 | $39.0K |
| Deferred revenue recorded in accounts receivable | $2.3M | $732.0K |
| Purchase of fixed assets recorded in accounts payable | $47.0K | $77.0K |
| Transaction cost recorded in accounts payable | $0 | $15.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led OmniAb, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
2025
- Chief executive officerMatthew W. Foehr Nov 3, 2022 to now9
- Chief executive officerDavid F. Burgstahler Aug 9, 2021 to Aug 9, 202110
- PresidentMatthew W. Foehr Nov 3, 2022 to now9
- PresidentDavid F. Burgstahler Aug 9, 2021 to Aug 9, 202110
- Chief financial officerKurt A. Gustafson Nov 3, 2022 to now11
- Chief financial officerJohn Cafasso Aug 10, 2021 to Aug 10, 202112
- Chief operating officerAmechi Ekeke Nwachuku Jul 13, 2026 to now13
Board members and other officers (19)
- OfficerCharles S. Berkman Nov 3, 2022 to Jan 5, 202314
- Investor Relations OfficerAmanda N. Heravi Aug 9, 2021 to Aug 9, 202115
- Executive Vice PresidentRobert Girardi Aug 9, 2021 to Aug 9, 202116
- Executive Vice PresidentSriram Venkataraman Aug 9, 2021 to Aug 9, 202117
- Board memberSteven C. Crouse Apr 21, 2025 to now18
- Board memberCharles C. Harwood Jr. Aug 25, 2022 to Aug 25, 202219
- Board memberCarolyn R. Bertozzi Nov 3, 2022 to now20
- Board memberJennifer R. Cochran Nov 3, 2022 to now21
- Board memberJoshua Alexander Tamaroff Nov 3, 2022 to Jun 21, 202422
- Board memberMatthew W. Foehr Nov 3, 2022 to now9
- Board memberSarah Boyce Nov 3, 2022 to Jun 21, 202423
- Board memberSunil Patel Nov 3, 2022 to Jun 27, 202324
- Board memberDavid F. Burgstahler Aug 9, 2021 to Jun 21, 202410
- Board memberLale White Aug 9, 2021 to Aug 9, 202125
- Board memberThompson Dean Aug 9, 2021 to Jun 21, 202410
- Board memberWendel Barr Aug 9, 2021 to Aug 9, 202126
- Board memberWilliam E. Klitgaard Aug 9, 2021 to Aug 9, 202127
- General counselCharles S. Berkman Feb 17, 2023 to now28
- General counselBenjamin Silbert Aug 9, 2021 to Aug 9, 202129
Former names
- Avista Public Acquisition Corp. IIMar 19, 2021 to Nov 1, 20222
Timeline
Filings
354 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 40 major events, 164 insider forms, 27 large holders, 1 private raises, 101 other. The latest 20:
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Aug 3, 20264 EDGAR
- Jul 13, 20263 EDGAR
- Jul 13, 20268-K EDGAR
- Jun 18, 20264 EDGAR
- Jun 18, 20264 EDGAR
- Jun 18, 20264 EDGAR
- Jun 18, 20268-K EDGAR
- Jun 18, 20264 EDGAR
- Jun 18, 20264 EDGAR
- Jun 18, 20264 EDGAR
- May 7, 202610-Q EDGAR
- May 7, 20268-K EDGAR
- Apr 29, 2026ARS EDGAR
- Apr 29, 2026DEFA14A EDGAR
- Apr 29, 2026DEF 14A EDGAR
- Apr 21, 20264 EDGAR
- Apr 21, 20264 EDGAR
The 354 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 27 such filings since October 2021, the latest 10:
- Aug 14, 2026SCHEDULE 13G/A
- Feb 10, 2026SCHEDULE 13G/A
- Nov 14, 2025SCHEDULE 13G/A
- Aug 27, 2025SCHEDULE 13G/A
- Aug 14, 2025SCHEDULE 13G/A
- Aug 14, 2025SCHEDULE 13G/A
- Jul 1, 2025SCHEDULE 13G
- Jun 6, 2025SCHEDULE 13G
- May 14, 2025SCHEDULE 13G/A
- Nov 14, 2024SC 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Money raised
Private offerings the company reported to the SEC on Form D.
- Aug 26, 2025Raised $30 million in a private offering of equity Form D: 15 investors so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| LMR Partners LLP | 897,392 | $79.6K | 0.0% | No change |
| Aristeia Capital, L.l.c. | 679,919 | $53.5K | 0.0% | No change |
| Hudson Bay Capital Management LP | 465,229 | $41.3K | 0.0% | No change |
| Anson Funds Management LP | 11,833 | $29.1K | 0.0% | −11,833 |
| Sculptor Capital LP | 293,802 | $23.1K | 0.0% | No change |
| Calamos Advisors LLC | 200,000 | $16.7K | 0.0% | No change |
| MMCAP International Inc. SPC | 158,333 | $14.0K | 0.0% | No change |
| Css Llc/il | 54,656 | $4.8K | 0.0% | No change |
| Wolverine Asset Management LLC | 27,626 | $2.5K | 0.0% | +301 |
| Saba Capital Management, L.P. | 18,000 | $1.4K | 0.0% | −1,900 |
| UBS Group AG | 19,737 | $1.1K | 0.0% | No change |
| OMERS ADMINISTRATION Corp | 10,000 | $751 | 0.0% | No change |
| Clear Street Group Inc. | 100 | $9 | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAROmniAb, Inc. filings on SEC EDGAR
- 2SEC EDGAROmniAb, Inc. filings on SEC EDGAR
- 3SEC EDGAROmniAb, Inc. 10-K for fiscal 2025
- 4SEC EDGAROmniAb, Inc. 10-K for fiscal 2021
- 5SEC EDGAROmniAb, Inc. 10-K for fiscal 2022
- 6SEC EDGAROmniAb, Inc. 10-K for fiscal 2023
- 7SEC EDGAROmniAb, Inc. 10-Q for fiscal 2026
- 8SEC EDGAROmniAb, Inc. 10-Q for fiscal 2026
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARCharles S. Berkman, Officer
- 15
- 16
- 17
- 18SEC EDGARSteven C. Crouse, Board member
- 19SEC EDGARCharles C. Harwood Jr., Board member
- 20SEC EDGARCarolyn R. Bertozzi, Board member
- 21SEC EDGARJennifer R. Cochran, Board member
- 22
- 23SEC EDGARSarah Boyce, Board member
- 24SEC EDGARSunil Patel, Board member
- 25SEC EDGARLale White, Board member
- 26SEC EDGARWendel Barr, Board member
- 27SEC EDGARWilliam E. Klitgaard, Board member
- 28SEC EDGARCharles S. Berkman, General counsel
- 29SEC EDGARBenjamin Silbert, General counsel